Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy

Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy

Bibliographic Details
Main Authors: Takashi Uehara, Hiroshi Yoshida, Tomoyasu Kato
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:Gynecologic Oncology Reports
Subjects:
Endometriosis
Estrogen replacement therapy
Metachronous tumor
Seromucinous borderline tumor
Serous adenocarcinoma
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578920301582
id doaj-31d3175336c84467b0db304b26528c0a
record_format Article
spelling doaj-31d3175336c84467b0db304b26528c0a2021-02-11T04:21:47ZengElsevierGynecologic Oncology Reports2352-57892021-02-0135100692Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapyTakashi Uehara0Hiroshi Yoshida1Tomoyasu Kato2Department of Gynecology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan; Corresponding author at: Department of Obstetrics and Gynecology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan.Department of Diagnostic Pathology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, JapanDepartment of Gynecology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japanhttp://www.sciencedirect.com/science/article/pii/S2352578920301582EndometriosisEstrogen replacement therapyMetachronous tumorSeromucinous borderline tumorSerous adenocarcinoma
collection DOAJ
language English
format Article
sources DOAJ
author Takashi Uehara
Hiroshi Yoshida
Tomoyasu Kato
spellingShingle Takashi Uehara
Hiroshi Yoshida
Tomoyasu Kato
Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy
Gynecologic Oncology Reports
Endometriosis
Estrogen replacement therapy
Metachronous tumor
Seromucinous borderline tumor
Serous adenocarcinoma
author_facet Takashi Uehara
Hiroshi Yoshida
Tomoyasu Kato
author_sort Takashi Uehara
title Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy
title_short Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy
title_full Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy
title_fullStr Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy
title_full_unstemmed Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy
title_sort pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy
publisher Elsevier
series Gynecologic Oncology Reports
issn 2352-5789
publishDate 2021-02-01
topic Endometriosis
Estrogen replacement therapy
Metachronous tumor
Seromucinous borderline tumor
Serous adenocarcinoma
url http://www.sciencedirect.com/science/article/pii/S2352578920301582
work_keys_str_mv AT takashiuehara pelvicseromucinousborderlinetumor26yearsafterovarianseromucinousborderlinetumormanagedwithposttreatmentestrogenreplacementtherapy
AT hiroshiyoshida pelvicseromucinousborderlinetumor26yearsafterovarianseromucinousborderlinetumormanagedwithposttreatmentestrogenreplacementtherapy
AT tomoyasukato pelvicseromucinousborderlinetumor26yearsafterovarianseromucinousborderlinetumormanagedwithposttreatmentestrogenreplacementtherapy
_version_ 1724274586027032576

Similar Items